CompletedNCT00183443
Comparing medication treatments for mania in people with bipolarity or schizophrenia
About this title
Read the official source — NCT00183443Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Palo AltoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateFebruary 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- Palo Alto Veterans Institute for Research
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00183443
- Official title
Show the full official title
Divalproex Extended Release and Placebo, Lithium, or Quetiapine for Mania
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Palo Alto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Palo Alto Veterans Institute for Research, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Divalproex-extended release (DVP-ER), lithium and Quetiapine.
Who was this study for?
Listed age limits: 18 years to 65 years.
